Elodie Masson
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes 2
- Emergency Medicine top 10%
- Clinical Biochemistry top 10%
-
- Glycosylation and Glycoproteins Research 8
- Sphingolipid Metabolism and Signaling 5
- Peroxisome Proliferator-Activated Receptors 3
-
- Cholesterol and Lipid Metabolism 4
-
- Carbohydrate Chemistry and Synthesis 3
-
- Pregnancy and preeclampsia studies 2
-
- Adipose Tissue and Metabolism 2
In The Last Decade
Elodie Masson
24 papers receiving 826 citations
Peers
Comparison fields: 5 of 84
- Nephrology 81
- Emergency Medicine 91
- Clinical Biochemistry 62
- Molecular Biology 482
- Immunology 144
Countries citing papers authored by Elodie Masson
This map shows the geographic impact of Elodie Masson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elodie Masson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elodie Masson more than expected).
Fields of papers citing papers by Elodie Masson
This network shows the impact of papers produced by Elodie Masson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elodie Masson. The network helps show where Elodie Masson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elodie Masson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 8 | |
| 4 | 2019 | 10 | |
| 5 | 2018 | 10 | |
| 6 | 2018 | 0 | |
| 7 | 2016 | 4 | |
| 8 | 2015 | 90 | |
| 9 | 2015 | 22 | |
| 10 | 2013 | 58 | |
| 11 | 2013 | 129 | |
| 12 | 2013 | 29 | |
| 13 | 2010 | 128 | |
| 14 | 2009 | 39 | |
| 15 | Hcb-19/TxNIP-/- Mice are Resistant to Streptozotocin (STZ)-Induced Diabetes | 2008 | 1 |
| 16 | 2008 | 1 | |
| 17 | 2006 | 33 | |
| 18 | 2005 | 23 | |
| 19 | 2004 | 14 | |
| 20 | 2003 | 26 |
About Elodie Masson
Elodie Masson is a scholar working on Sensory Systems, Clinical Biochemistry and Nephrology, having authored 26 papers that have together received 835 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (8 papers), Sphingolipid Metabolism and Signaling (5 papers), Cholesterol and Lipid Metabolism (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Carbohydrate Chemistry and Synthesis (3 papers), Pregnancy and preeclampsia studies (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Nephrology (81 citations), Emergency Medicine (91 citations) and Clinical Biochemistry (62 citations). Elodie Masson has collaborated with scholars based in France, Canada and Morocco. Frequent co-authors include Tarik Issad, Patrick Pagésy, Michel Lagarde, Nicolas Wiernsperger, Samer El Bawab, Eric A. Shikatani, Ling Xia, Mansoor Husain, Abdul Momen and Rohan John. Their work appears in journals such as PLoS ONE, Diabetes and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.